Mr. Yaniv Kotler (LLB, M.Sc.)
CEO & Founder
Experience: 16 year biotech entrepreneur, established biotechnology start-up (Kovax) sold it in 2018 to Phibro. Serving in various executive roles for 25 years.
Dr. Miriam Ben Hirsch Gornemann (M.D, PhD, M.P.H)
Chief Scientific Officer
Experience: An epidemiologist with more than 30 years’ experience as a clinical and community researcher, research promoter, director of research, management, teaching and consulting in the USA, Spain and Israel
Orit Kotler (B.A, M.A.)
Chief Strategy Officer
Experience: 26 years in high tech/biotech, managed multi $ M projects in corporate and private companies. CEO of Kovax Ltd, sold to Phibro (2018).
Dr. Yoav Smith (Ph.D.)
Chief Technology Officer
Experience: Specializing in genomic analysis, machine learning algorithms, big data analysis and bioinformatics. Specialized in analysis of various types of biological and clinical data using advanced computing tools .
Yuval Zuk ( B.Sc, EMBA):
Chief Operating Officer
Experience: 25 Years Med-Device Industry entrepreneur and CEO roles, Odin Medical Technologies, MRI guidance systems for neurosurgery sold to Medtronic Inc. Activiews Ltd. surgical tool guidance sold to Stryker Inc.
The company has a firm IP which includes 1 granted (USA), 4 PCT, 1 provisional, jointly owned with Hebrew University, Israel